Aytu Biopharma Inc (NQ: AYTU )

3.850 USD +0.020 (+0.52%)

Streaming Delayed Price Updated: 12:05 PM EDT, Aug 5, 2021 Add to My Watchlist

Price and Volume

Volume	167,856
Open	3.850
Bid (Size)	3.850 (2)
Ask (Size)	3.860 (2)
Prev. Close	3.830
Today's Range	3.800 - 3.870
52wk Range	3.760 - 14.50
Shares Outstanding	25,170,596
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aytu BioPharma Announces Publication of Data Demonstrating Ultraviolet-A Light Reduces Cellular Cytokine Release from Human Endotracheal Cells Infected with Coronavirus

July 27, 2021

Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study

June 28, 2021

Performance

YTD	-38.20%	-38.20%
1 Month	-19.79%	-19.79%
3 Month	-34.75%	-34.75%
6 Month	-50.64%	-50.64%
1 Year	-72.89%	-72.89%

More News

7 Top Penny Stocks to Watch Right Now With Big News

June 21, 2021

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

July 21, 2021

12 Health Care Stocks Moving In Tuesday's Intraday Session

June 22, 2021

Technical Levels To Watch In Aytu BioPharma Stock

June 21, 2021

12 Health Care Stocks Moving In Monday's Intraday Session

June 21, 2021

Thinking about buying stock in Anavex Life Sciences, Globalstar, Rapt Therapeutics, Aytu Biopharma, or Evofem Biosciences?

June 21, 2021

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

Today 8:04 EDT

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings

August 04, 2021

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal

July 28, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.